Examining the association of smoking with work productivity and associated costs in Japan

被引:25
|
作者
Suwa, Kiyomi [1 ]
Flores, Natalia M. [2 ]
Yoshikawa, Reiko [1 ]
Goto, Rei [3 ]
Vietri, Jeffrey [4 ]
Igarashi, Ataru [5 ]
机构
[1] Pfizer Japan Inc, Shibuya Ku, Tokyo, Japan
[2] Kantar Hlth, Hlth Outcomes Practice, Foster City, CA USA
[3] Keio Univ, Keio Business Sch, Grad Sch Business Adm, Yokohama, Kanagawa, Japan
[4] Kantar Hlth, Hlth Outcomes Practice, Horsham, PA USA
[5] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Drug Policy & Management, Tokyo, Japan
关键词
Smoking cessation; Work productivity; Activity impairment; Indirect costs; SCALE MANUFACTURING ENTERPRISES; CESSATION; LIFE; SYMPTOMS; GERMANY; SAVINGS; SMOKERS;
D O I
10.1080/13696998.2017.1352507
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Smoking is associated with significant health and economic burden globally, including an increased risk of many leading causes of mortality and significant impairments in work productivity. This burden is attenuated by successful tobacco cessation, including reduced risk of disease and improved productivity. The current study aimed to show the benefits of smoking cessation for work-place productivity and decreased costs associated with loss of work impairment. Materials and methods: The data source was the 2011 Japan National Health and Wellness Survey (n=30,000). Respondents aged 20-64 were used in the analyses (n=23,738) and were categorized into: current smokers, former smokers, and never smokers. Generalized linear models controlling for demographics and health characteristics examined the relationship of smoking status with the Work Productivity and Activity Impairment questionnaire (WPAI-GH) endpoints, as well as estimated indirect costs. Results: Current smokers reported the greatest overall work impairment, including absenteeism (i.e. work time missed) and presenteeism (i.e. impairment while at work); however, after controlling for covariates, there were no significant differences between former smokers and never smokers on overall work impairment. Current smokers and former smokers had greater activity impairment (i.e. impairment in daily activities) than never smokers. Current smokers reported the highest indirect costs (i.e. costs associated with work impairment); however, after controlling for covariates, there were no significant differences between former smokers and never smokers on indirect costs. Limitations and conclusions: Smoking exerts a large health and economic burden; however, smoking cessation attenuates this burden. The current study provides important further evidence of this association, with former smokers appearing statistically indistinguishable from never smokers in terms of work productivity loss and associated indirect costs among a large representative sample of Japanese workers. This report highlights the workplace benefits of smoking cessation across productivity markers and cost-savings.
引用
收藏
页码:938 / 944
页数:7
相关论文
共 50 条
  • [21] Smoking And Asthma: Examining Factors Associated With Smoking In Ontario Teenagers With Asthma
    Larsen, K.
    To, T.
    Mann, R.
    Boak, A.
    Hamilton, H.
    Faulkner, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [22] The Effects of Smoking on Dental Care Utilization and Its Costs in Japan
    Ide, R.
    Hoshuyama, T.
    Wilson, D.
    Takahashi, K.
    Higashi, T.
    JOURNAL OF DENTAL RESEARCH, 2009, 88 (01) : 66 - 70
  • [23] Smoking Cessation Is Associated With Lower Indirect Costs
    Baker, Christine L.
    Bruno, Marianna
    Emir, Birol
    Li, Vicky W.
    Goren, Amir
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2018, 60 (06) : 490 - 495
  • [24] Costs of the health care in Russia associated with smoking
    Kontsevaya, A. V.
    Kalinina, A. M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (03) : 306 - 312
  • [25] ESTIMATING DIRECT COSTS AND PRODUCTIVITY COSTS ASSOCIATED WITH RAPID INFUSION OF DARATUMUMAB
    Reese, E.
    Hamadeh, I
    Schneider, M.
    Williams, A. A.
    Arnall, J.
    Kachur, E.
    Martin, A.
    Bhutani, M.
    Atrash, S.
    Friend, R.
    Paul, B.
    Robinson, J.
    Ndiaye, A.
    Sprouse, C.
    Usmani, S. Z.
    VALUE IN HEALTH, 2019, 22 : S501 - S501
  • [26] The costs of health damage and productivity losses attributable to cigarette smoking in Germany
    Welte, R
    König, HH
    Leidl, R
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2000, 10 (01): : 31 - 38
  • [27] The economic burden of smoking in Belgium: incremental healthcare costs and lost productivity
    Vynckier, Pieter
    Schmidt, Masja
    Nayani, Sarah
    Guariguata, Leonor
    Devleesschauwer, Brecht
    Verhaeghe, Nick
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2025, 35 (01): : 108 - 113
  • [28] Modelling of the costs of productivity losses due to smoking in Germany for the year 2005
    Prenzler, A.
    Mittendorf, T.
    von der Schulenburg, J. M.
    GESUNDHEITSWESEN, 2007, 69 (11) : 635 - 643
  • [29] The Association of Treatment of Depressive Episodes and Work Productivity
    Dewa, Carolyn S.
    Thompson, Angus H.
    Jacobs, Phillip
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2011, 56 (12): : 743 - 750
  • [30] WORK PRODUCTIVITY AND COSTS RELATED TO PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Walter, E.
    Hausberger, S. C.
    Gross, E.
    VALUE IN HEALTH, 2019, 22 : S624 - S624